These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8792645)

  • 21. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA; Nau CB; McLaren JW; Johnson DH
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of haloperidol on testicular functions in rat.
    Mukherjee M; Ghosh A
    Indian J Exp Biol; 1997 Sep; 35(9):1014-5. PubMed ID: 9475081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.
    Chiou GC; Chen YJ
    J Ocul Pharmacol; 1992; 8(4):285-94. PubMed ID: 1484260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [About the effect of adrenalin-containing eye drops on the intraocular tension in normal and glaucomatous eyes].
    Stein HJ
    Klin Monbl Augenheilkd; 1966; 149(5):725-36. PubMed ID: 5994674
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension.
    Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
    Jpn J Ophthalmol; 2004; 48(3):276-80. PubMed ID: 15175922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental justification of pathogenetically directed glaucoma therapy].
    Kryzhanovskiĭ GN; Kashintseva LT; Lipovetskaia EM; Kopp OP
    Oftalmol Zh; 1980; 35(8):493-7. PubMed ID: 6111059
    [No Abstract]   [Full Text] [Related]  

  • 28. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2007 Mar; 23(3):595-9. PubMed ID: 17355740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of lithium hydroxybutyrate on intraocular pressure and the blood supply of ocular vessels].
    Kryzhanovskiĭ GN; Kashintseva LT; Lipovetskaia EM; Kopp OP
    Oftalmol Zh; 1984; (6):366-9. PubMed ID: 6504485
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipid peroxidation in experimental adrenaline-induced glaucoma].
    Mikheĭtseva IN
    Oftalmol Zh; 1989; (7):427-8. PubMed ID: 2633096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits.
    Prünte C; Nuttli I; Markstein R
    Jpn J Ophthalmol; 1996; 40(2):167-73. PubMed ID: 8876383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the effect of clonidine on ocular and brachial pressure with normal intraocular pressure, with glaucoma simplex chronicum and with juvenile].
    Marquardt R
    Buch Augenarzt; 1974; 63():116-7. PubMed ID: 4856174
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.
    Zeitz O; Galambos P; Matthiesen N; Wagenfeld L; Schillinger W; Wiermann A; Richard G; Klemm M
    Med Sci Monit; 2008 May; 14(5):CR268-275. PubMed ID: 18443551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the action of Ismelin eye drops in normal and glaucomatous eyes].
    Gonçalves JO
    Rev Bras Oftalmol; 1971 Jun; 30(2):155-75. PubMed ID: 5562463
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of effects of clofibrate, an antilipaemic agent on intraocular pressure in experimental glaucoma.
    Gupta MC; Khosla P; Garg KN
    Indian J Ophthalmol; 1985; 33(5):313-5. PubMed ID: 3843342
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
    Greenfield DS; Liebmann JM; Ritch R; Krupin T;
    Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.